Evidence & Risk Memos
Operator-grade analysis of clinical claims, evidence quality, radiology workflow fit, regulatory constraints, reimbursement reality, and adoption risk — across radiology AI, med-tech devices, and advanced materials (including graphene).
Do not submit PHI or patient identifiers. This is research and analysis—not medical, legal, or financial advice.
When a memo is the fastest path to clarity
A memo is for decisions where the cost of being wrong is high — capital, time, reputation, or clinical risk.
- You're evaluating a radiology AI tool and need to know if it will actually work in real workflow
- You're assessing a med-tech device and want to understand adoption blockers, evidence strength, and reimbursement reality
- You're hearing big claims (accuracy, outcomes, "game-changing") and want the evidence graded and summarized
- You need a clear risk register before pilots, demos, fundraising, or procurement conversations
- You want to avoid expensive "build-first" mistakes and confirm the real constraints
What you receive
- Executive summary (what matters, what doesn't)
- Evidence synthesis with citations (what the data actually shows)
- Workflow fit analysis (who uses it, where friction happens, what adoption requires)
- Regulatory + reimbursement constraints (what can break commercialization)
- Risk register + failure modes (how this fails in the real world)
- Competitive landscape snapshot (who's adjacent and who's direct)
- Decision triggers (what would change the conclusion)
If you request it, we can format the memo for internal leadership distribution (clean headings, short sections, no fluff).
Common memo types
Radiology Workflow & AI Adoption Memo
A practical evaluation of radiology AI claims through the lens of workflow, liability, and real-world adoption.
- Structured reporting + guideline logic (LI-RADS / BI-RADS / TI-RADS)
- PACS/RIS friction, interruptions, and "time-to-use" reality
- False positives/negatives and downstream workflow cost
- Who actually benefits: radiologist, trainee, coder, admin, patient?
Med-Tech Device Evidence & Commercialization Memo
Evidence strength, clinical fit, and commercialization constraints for devices in IR/OR/procedural medicine.
- Evidence quality and endpoint relevance
- Training burden and procedure time impact
- Adoption drivers: hospital purchasing, physician incentives, workflow disruption
- Reimbursement and coding considerations (where applicable)
Graphene & Advanced Materials Commercialization Memo
A sober assessment of graphene/materials claims, scalable manufacturing realities, and credible use cases.
- What "graphene" means in this product (flake vs film vs composites)
- Manufacturing scalability and QC bottlenecks
- Where value is real (and where it's marketing)
- Partner strategy and licensing pathways (high-level)
Healthcare Automation / RAG System Memo
When a team wants an "AI copilot," this memo clarifies what's feasible, what data is needed, and what to build first.
- RAG viability and knowledge source quality
- Security boundaries and no-PHI starting points
- Human-in-the-loop design and failure handling
- What an MVP should actually include (and what to skip)
Process
You submit the request (what decision you're making + what you're evaluating)
We confirm scope and timeline by email (we keep it tight)
You receive a structured memo with sources and a clear conclusion
Optional: brief call to clarify findings (if requested)
Inputs (keep it simple)
- A short description of the decision you're making (1 paragraph)
- What's being evaluated (tool/device/company/material)
- Any key materials you already have (deck, website, papers) — optional but helpful
- Your timeline and what a "good outcome" looks like
If you have NDAs or sensitive materials, mention it in the intake and we'll reply with next steps.
Optional add-ons
- 30-minute clarity call after delivery (to discuss implications)
- Partner shortlist (high-level; not solicitation)
- Spec Sprint for teams who want a build plan after the memo
Related resources
Guides and tools that complement the memo process.
FAQ
No. We provide research and analysis to clarify evidence, constraints, and risk.
No. Do not submit PHI or patient identifiers through intake forms.
Yes. Many memos focus on workflow, evidence, and adoption risk before any integration is considered.
Yes. If the memo supports it, we can scope a build via a Spec Sprint and route you to the right path.
That's fine. We can still assess what's credible, what's missing, and what would be required to validate.
Request a Memo
If a claim matters, don't guess. Submit the request and we'll reply by email with scope and timeline.
We provide research and analysis. Not medical, legal, or financial advice.